Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
InfuSystem Holdings ( (INFU) ) just unveiled an update.
InfuSystem Holdings, Inc. announced that it will release its third-quarter 2025 financial results on November 4, 2025, before the market opens. The company will also hold a conference call on the same day to discuss the financial results, providing stakeholders with insights into its performance and future outlook.
The most recent analyst rating on (INFU) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.
Spark’s Take on INFU Stock
According to Spark, TipRanks’ AI Analyst, INFU is a Outperform.
InfuSystem Holdings demonstrates robust financial performance and strategic initiatives, particularly in revenue growth and cash flow. However, high valuation metrics and overbought technical indicators suggest caution. The earnings call and corporate events provide a positive outlook, but challenges in specific segments temper the overall score.
To see Spark’s full report on INFU stock, click here.
More about InfuSystem Holdings
InfuSystem Holdings, Inc. is a national healthcare service provider that facilitates outpatient care for durable medical equipment manufacturers and healthcare providers. The company operates under a two-platform model: Patient Services, which includes Oncology, Pain Management, and Wound Therapy, and Device Solutions, which offers direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in Rochester Hills, Michigan, InfuSystem also has Centers of Excellence in several U.S. states and Ontario, Canada.
Average Trading Volume: 257,839
Technical Sentiment Signal: Buy
Current Market Cap: $206.9M
Learn more about INFU stock on TipRanks’ Stock Analysis page.